Hereditary syndromal and nonsyndromal forms of primary hyperparathyroidism
Open Access
- 4 August 2020
- journal article
- abstracts
- Published by Endocrinology Research Centre in Problems of Endocrinology
- Vol. 66 (1) , 23-34
Abstract
Primary hyperparathyroidism is a common disorder of mineral homeostasis, characterized by overproduction of parathyroid hormone and upper normal or elevated calcium levels due to hyperplasia or a tumor of parathyroid gland. 9095% of cases of primary hyperparathyroidism are sporadic, while hereditary genetic forms occur in 510% of all cases. Primary hyperparathyroidism as the component of hereditary syndromes can present in various clinical forms (asymptomatic, symptomatic), can be associated with other endocrine or non-endocrine diseases, and require special approaches to treatment. Given that primary hyperparathyroidism is one of the most common components of these syndromes, it can be used as an important diagnostic tool in identifying affected families. This review is devoted to modern ideas about the clinical course and genetic characteristics of hereditary variants of primary hyperparathyroidism and the diagnostic and treatment algorithms recommended today. The review considers primary hyperparathyroidism as a component of hereditary syndromes including multiple endocrine neoplasias types 1, 2A and 4 and syndrome of hyperparathyroidism with a jaw tumor. Also non-syndromic hereditary forms are descripted, such as familial isolated hyperparathyroidism, familial hypocalciuric hypercalcemia, and severe neonatal primary hyperparathyroidism.Keywords
This publication has 63 references indexed in Scilit:
- Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4)Molecular and Cellular Endocrinology, 2014
- Differences between sporadic and MEN related primary hyperparathyroidism; clinical expression, preoperative workup, operative strategy and follow-upOrphanet Journal of Rare Diseases, 2013
- Hereditary Hyperparathyroidism SyndromesJournal of Clinical Densitometry, 2013
- Cinacalcet in the management of primary hyperparathyroidism: post marketing experience of an Italian multicentre groupClinical Endocrinology, 2012
- Genetic and Clinical Features of Multiple Endocrine Neoplasia Types 1 and 2Journal of Oncology, 2012
- Multiple endocrine neoplasias: advances and challenges for the futureJournal of Internal Medicine, 2009
- Rare Germline Mutations in Cyclin-Dependent Kinase Inhibitor Genes in Multiple Endocrine Neoplasia Type 1 and Related StatesThe Journal of Clinical Endocrinology & Metabolism, 2009
- The utility of routine transcervical thymectomy for multiple endocrine neoplasia 1-related hyperparathyroidismSurgery, 2008
- Developing Effective Screening Strategies in Multiple Endocrine Neoplasia Type 1 (MEN 1) on the Basis of Clinical and Sequencing Data of German Patients with MEN 1Experimental and Clinical Endocrinology & Diabetes, 2007
- Germ-line mutations in p27
Kip1
cause a multiple endocrine neoplasia syndrome in rats and humansProceedings of the National Academy of Sciences, 2006